Use of the MQoL-HIV with asymptomatic HIV-positive patients

被引:67
作者
Smith, KW
Avis, NE
Mayer, KH
Swislow, L
机构
[1] FENWAY COMMUNITY HLTH CTR,BOSTON,MA
[2] CAMBRIDGE HOSP,CAMBRIDGE,MA 02139
关键词
quality of life; HIV; responsiveness; questionnaire; MOS SF-20;
D O I
10.1023/A:1018412216638
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this study was to determine the appropriateness of the recently developed Multidimensional Quality of Life Questionnaire for HIV/AIDS (MQoL-HIV) as a measure of quality of rife (QoL) in cases of asymptomatic human immunodeficiency virus (HIV) infection. The MQoL-HIV is a 40-item instrument measuring ten domains (mental hearth, physical health, physical functioning, social functioning, social support, cognitive functioning, financial status, partner intimacy, sexual functioning and medical care) relevant to HIV infection. An overall QoL score, the MQoL-HIV Index, is a weighted composite of two domain scores. In a sample of 216 HIV-infected men and women, the MQoL-HIV distinguished acquired immune deficiency syndrome (AIDS), symptomatic and asymptomatic cases in overall QoL and in seven individual QoL domains. The index was responsive to perceived QoL changes over 5.5 months (r = 0.52). We also found the MQoL-HIV was less susceptible to ceiling effects in asymptomatic cases than was the Medical Outcomes Study (MOS) SF-20. These results suggest that the MQoL-HIV is a valid and reliable measure of QoL for both asymptomatic and symptomatic HIV infection.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 8 条
[1]  
AVIS NE, MULTIDIMENSIONAL QUA
[2]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[3]   TIME TO HIT HIV, EARLY AND HARD [J].
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :450-451
[4]   SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample [J].
Holmes, W ;
Bix, B ;
Shea, J .
MEDICAL CARE, 1996, 34 (06) :562-569
[5]   EFFECT SIZES FOR INTERPRETING CHANGES IN HEALTH-STATUS [J].
KAZIS, LE ;
ANDERSON, JJ ;
MEENAN, RF .
MEDICAL CARE, 1989, 27 (03) :S178-S189
[6]  
SMITH KW, 1996, 11 INT C AIDS VANC 9
[7]  
Streiner D.L., 1998, Health Measurement Scales: A Practical Guide to their Development and Use, V2nd
[8]   AN INDEX OF SYMPTOMS FOR INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS - RELIABILITY AND VALIDITY [J].
WHALEN, CC ;
ANTANI, M ;
CAREY, J ;
LANDEFELD, CS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (05) :537-546